AAM Biotechnology Opp 15M CDA 2021-1 CA
Fund
BOPABX
Price as of:
$9.78
+ $0.03
+ 0.29%
Primary Theme
N/A
fund company
Name
As of 08/31/2021Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
$9.78
-
0.00%
0.39%
Vitals
YTD Return
N/A
1 yr return
N/A
3 Yr Avg Return
N/A
5 Yr Avg Return
N/A
Net Assets
$N/A
Holdings in Top 10
42.8%
52 WEEK LOW AND HIGH
$9.8
$7.85
$9.93
Expenses
OPERATING FEES
Expense Ratio 0.39%
SALES FEES
Front Load 0.00%
Deferred Load 1.25%
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
N/A
Fund Classification
Fund Type
Unknown
Name
As of 08/31/2021Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
$9.78
-
0.00%
0.39%
BOPABX - Profile
Distributions
- YTD Total Return N/A
- 3 Yr Annualized Total Return N/A
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio N/A
- Dividend Yield 0.0%
- Dividend Distribution Frequency Semi-Annually
Fund Details
-
Legal NameBiotechnology Opportunities Portfolio - 15 Month, CDA Series 2021-1Q
-
Fund Family NameAdvisors Asset Management, Inc.
-
Inception DateFeb 09, 2021
-
Shares OutstandingN/A
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUnited States
Fund Description
BOPABX - Performance
Return Ranking - Trailing
Period | BOPABX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -38.9% | 25.3% | N/A |
1 Yr | N/A | -60.2% | 33.9% | N/A |
3 Yr | N/A* | -10.0% | 19.7% | N/A |
5 Yr | N/A* | -6.4% | 16.9% | N/A |
10 Yr | N/A* | 6.4% | 18.5% | N/A |
* Annualized
Return Ranking - Calendar
Period | BOPABX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -79.9% | 25.9% | N/A |
2022 | N/A | -13.6% | 178.2% | N/A |
2021 | N/A | 3.8% | 63.8% | N/A |
2020 | N/A | -49.7% | 21.5% | N/A |
2019 | N/A | -59.8% | 54.4% | N/A |
Total Return Ranking - Trailing
Period | BOPABX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -46.5% | 25.3% | N/A |
1 Yr | N/A | -60.2% | 31.1% | N/A |
3 Yr | N/A* | -15.9% | 20.0% | N/A |
5 Yr | N/A* | -7.4% | 16.9% | N/A |
10 Yr | N/A* | 6.4% | 18.5% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | BOPABX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -79.9% | 25.9% | N/A |
2022 | N/A | -13.6% | 178.2% | N/A |
2021 | N/A | 3.8% | 63.8% | N/A |
2020 | N/A | -49.7% | 22.2% | N/A |
2019 | N/A | -59.8% | 54.4% | N/A |
NAV & Total Return History
BOPABX - Holdings
Concentration Analysis
BOPABX | Category Low | Category High | BOPABX % Rank | |
---|---|---|---|---|
Net Assets | N/A | 732 K | 46.2 B | N/A |
Number of Holdings | 36 | 11 | 473 | 77.87% |
Net Assets in Top 10 | 4.28 K | 2.18 K | 21.6 B | 94.67% |
Weighting of Top 10 | 42.79% | 12.3% | 94.7% | 57.79% |
Top 10 Holdings
- BioNTech SE ADR 7.92%
- Moderna Inc 5.60%
- Intellia Therapeutics Inc 5.59%
- Biohaven Pharmaceutical Holding Co Ltd 4.16%
- NovoCure Ltd 3.55%
- Syneos Health Inc Class A 3.36%
- AstraZeneca PLC ADR 3.35%
- Genmab A/S ADR 3.24%
- Repligen Corp 3.21%
- Regeneron Pharmaceuticals Inc 3.21%
Asset Allocation
Weighting | Return Low | Return High | BOPABX % Rank | |
---|---|---|---|---|
Stocks | 100.00% | 85.37% | 106.13% | 19.26% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 49.18% |
Other | 0.00% | -22.99% | 3.38% | 52.87% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 49.18% |
Cash | 0.00% | -0.10% | 9.01% | 84.02% |
Bonds | 0.00% | 0.00% | 12.39% | 47.95% |
Stock Sector Breakdown
Weighting | Return Low | Return High | BOPABX % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 59.26% | 100.00% | 28.28% |
Utilities | 0.00% | 0.00% | 0.00% | 46.31% |
Technology | 0.00% | 0.00% | 22.69% | 50.41% |
Real Estate | 0.00% | 0.00% | 7.13% | 50.00% |
Industrials | 0.00% | 0.00% | 7.02% | 50.41% |
Financial Services | 0.00% | 0.00% | 1.85% | 57.79% |
Energy | 0.00% | 0.00% | 0.00% | 46.31% |
Communication Services | 0.00% | 0.00% | 9.11% | 49.18% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 52.87% |
Consumer Cyclical | 0.00% | 0.00% | 14.20% | 49.18% |
Basic Materials | 0.00% | 0.00% | 14.83% | 61.48% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | BOPABX % Rank | |
---|---|---|---|---|
US | 81.20% | 53.67% | 104.41% | 68.44% |
Non US | 18.80% | 0.00% | 45.40% | 23.77% |
BOPABX - Expenses
Operational Fees
BOPABX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.39% | 0.08% | 3.13% | 71.43% |
Management Fee | N/A | 0.00% | 1.25% | N/A |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
BOPABX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | 0.00% | 0.00% | 5.75% | 70.24% |
Deferred Load | 1.25% | 1.00% | 5.00% | 69.14% |
Trading Fees
BOPABX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
BOPABX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | N/A | 0.00% | 238.00% | N/A |
BOPABX - Distributions
Dividend Yield Analysis
BOPABX | Category Low | Category High | BOPABX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 3.95% | 56.45% |
Dividend Distribution Analysis
BOPABX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Semi-Annually | Annually | Semi-Annually | Annually |
Net Income Ratio Analysis
BOPABX | Category Low | Category High | BOPABX % Rank | |
---|---|---|---|---|
Net Income Ratio | N/A | -2.54% | 1.92% | N/A |
Capital Gain Distribution Analysis
BOPABX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Semi-Annually | Semi-Annually |